Fufeng Group's stock price fell sharply on Thursday, dropping 17.5% to close at HK$4.48, after the company issued a profit warning that signalled a material earnings shortfall. The notice disclosed an estimated net loss of roughly RMB 53 million for the five-month period ended May 31, 2026.
The company attributed the bulk of the negative swing to foreign exchange losses of about RMB 540 million. Those losses arose because Fufeng held a substantial portion of its cash balances in US dollars while the US dollar weakened significantly versus the Chinese renminbi during the reporting period. The currency movement reduced the carrying value of those dollar-denominated assets when expressed in renminbi.
At the same time, selling prices for Fufeng's principal products - including monosodium glutamate (MSG) and other fermentation-based ingredients - remained under pressure throughout the period. The persistent softness in product pricing eroded gross profit margins and left the business with limited scope to absorb the currency-related losses.
The profit warning therefore combined two forces that translated into the reported net loss: a large FX mark-to-market charge and continued cyclical weakness in product pricing. The company framed the FX losses as a direct consequence of its exposure to US dollar cash holdings during a period when the renminbi strengthened materially against the dollar.
Investors reacted swiftly, reflecting concern that a rebound in selling prices may not occur quickly enough to offset the currency exposure embedded in the company’s global cash management posture. That market unease coincided with weakness across the Hong Kong market; the Hang Seng Index fell by about 1.7% on the day, with declines concentrated in auto and commodity-related stocks.
The profit warning and accompanying share-price move underline the sensitivity of Fufeng’s reported results to both currency fluctuations and commodity-cycle dynamics in fermentation products. The company’s statement detailed the estimated RMB 53 million loss and the roughly RMB 540 million FX impact but did not outline specific remedial measures or timing for any recovery in product prices.
Summary - Fufeng reported an estimated RMB 53 million net loss for the five months to May 31, 2026, driven largely by about RMB 540 million in foreign exchange losses and continued weakness in selling prices for core fermentation products. The stock fell 17.5% to HK$4.48 amid broader Hong Kong market weakness.
- Key points:
- Fufeng forecast an approximate RMB 53 million net loss for the five-month period ended May 31, 2026.
- Approximately RMB 540 million of foreign exchange losses were recorded due to significant holdings of US dollar cash while the US dollar weakened versus the renminbi.
- Soft selling prices for monosodium glutamate and other fermentation-based ingredients reduced gross profit and constrained the company’s ability to absorb the currency losses; the Hang Seng Index fell roughly 1.7% on the same day.
- Risks and uncertainties:
- Timing of any recovery in selling prices for MSG and other fermentation products is uncertain, which could prolong margin pressure - this affects companies in food ingredients and commodity chemicals sectors.
- Ongoing currency exposure from USD-denominated cash holdings creates volatility in reported results if exchange rates move unfavourably - this is a relevant risk for firms with global cash positions.
- Broader market weakness, as reflected in the Hang Seng’s decline, could exacerbate share-price volatility for companies in auto and commodity segments.